(Q36650373)

English

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial

scientific article published on 22 October 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

phase I clinical trial

0 references

monoclonal antibody

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Howard I. Scher

8

object named as

Howard I Scher

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

5

object named as

Susan F Slovin

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Emmanuel S. Antonarakis

1

object named as

Emmanuel S Antonarakis

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Michael A. Carducci

2

object named as

Michael A Carducci

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

Mario A Eisenberger

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Samuel R Denmeade

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Kathy Jelaca-Maxwell

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Martha E Vincent

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Michael J Morris

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

publication date

22 October 2011

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

69

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

763-771

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Monoclonal antibody therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586214

30 September 2017

Prostate stem cell antigen is overexpressed in prostate cancer metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586214

30 September 2017

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586214

30 September 2017

Prostate stem cell antigen is overexpressed in human transitional cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586214

30 September 2017

Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586214

30 September 2017

Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586214

30 September 2017

Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586214

30 September 2017

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586214

30 September 2017

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586214

30 September 2017

Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586214

30 September 2017

Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586214

20 September 2018

Anti–Prostate Stem Cell Antigen Monoclonal Antibody 1G8 Induces Cell DeathIn vitroand Inhibits Tumor GrowthIn vivovia a Fc-Independent Mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1759-9

21 January 2018

Identifiers

10.1007/S00280-011-1759-9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36650373&oldid=2201564809"